Keywords
Urinary Bladder Neoplasms ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

72 Search results.

Eligibility Bladder Cancer NCT01954173

- 8/18/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Adjuvant Radiation for High Risk Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01954173

Eligibility Locally Advanced or Metastatic Urothelial Cell Carcinoma NCT02401542

- 4/29/19 - 1 form, 1 itemgroup, 10 items, 1 language
Itemgroup: Criteria
A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02401542

Eligibility Solid Tumors NCT02240238

- 1/19/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238

Swedish Bladder Cancer Registry - 5-Year Follow-Up

- 11/19/17 - 1 form, 2 itemgroups, 15 items, 2 languages
Itemgroups: General Information, Follow-Up
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ 5-year Follow-Up

Swedish Bladder Cancer Registry - Cystectomy - Follow-Up

- 11/18/17 - 1 form, 5 itemgroups, 106 items, 2 languages
Itemgroups: General Information, Preoperative Data, Perioperative Data, Postoperative Data, Complications and Reoperations
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Cystectomy - Follow-Up

Swedish Bladder Cancer Registry - Treatment of Primary Tumor

- 11/15/17 - 1 form, 2 itemgroups, 30 items, 2 languages
Itemgroups: General Information, Treatment of Primary Tumor
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Treatment of Primary Tumor

Swedish Bladder Cancer Registry - Registry

- 11/15/17 - 1 form, 2 itemgroups, 27 items, 2 languages
Itemgroups: Registry, Tasks for Primary Diagnosis
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Registry

Eligibility Bladder Cancer NCT00389155

- 10/4/17 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00389155

Eligibility Carcinoma, Transitional Cell NCT00109655

- 11/7/16 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00109655

Eligibility Bladder Neoplasms NCT00001381

- 1/10/16 - 1 form, 1 itemgroup, 15 items, 1 language
Itemgroup: Criteria
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder; ODM derived from: https://clinicaltrials.gov/show/NCT00001381

On-Study Form Bladder Cancer NCT00014534 CALGB-90104

- 8/21/15 - 1 form, 3 itemgroups, 61 items, 1 language
Itemgroups: Muscle Invasive Bladder Disease: Prior Treatment Affecting the Bladder, Prior Therapy Date, CCRR MODULE
On-Study Form Bladder Cancer NCT00014534 CALGB-90104 NCT00014534 NCI Cooperative Group On-Study Form-Revised (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B6E9C-942E-7181-E034-0003BA12F5E7

Registration Bladder Cancer CALGB 90104 NCT00014534

- 7/30/15 - 1 form, 2 itemgroups, 34 items, 1 language
Itemgroups: Initial Patient Consent for Specimen Use, Registration
Registration Worksheet - 2169258v3.0 CALGB 90104 Registration Worksheet Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B0241-438C-6AC6-E034-0003BA12F5E7